Omega‑3 Fatty Acids in Pregnancy: Why They Matter for Mom and Baby

Omega‑3 fatty acids, especially EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), are important building blocks for both the mother’s health and the baby’s developing brain and eyes. During pregnancy, the demand for these fats increases because the fetus relies on the mother’s stores and intake to support rapid growth.

DHA is a major structural fat in the brain and retina. EPA helps regulate inflammation, blood flow, and signaling molecules that affect the cardiovascular system and mood. Because of these roles, researchers have focused on how omega‑3 intake in pregnancy may influence birth outcomes, child development, and maternal mental health.

Fetal Brain and Eye Development

The third trimester is a critical period for brain and eye development, and this is when DHA accumulation in the fetal brain is especially high. Studies show that higher maternal DHA levels are associated with:

• Better visual acuity in infants

• Improved early cognitive and problem‑solving scores in some follow‑up studies

• Healthier development of the nervous system overall

• 
  

While not every study finds the same degree of benefit, the overall pattern suggests that adequate DHA intake during pregnancy supports optimal neurodevelopment, especially when the mother’s baseline intake of oily fish is low.

Pregnancy Outcomes: Preterm Birth and Birth Weight

Omega‑3s may also influence key pregnancy outcomes such as gestational length and birth weight. Several randomized controlled trials and meta‑analyses have found that omega‑3 supplementation in pregnancy can:

• Reduce the risk of early preterm birth in some populations

• Slightly increase birth weight within a healthy range

• Modestly prolong gestation, helping babies reach a more mature stage before delivery

• 
  

These effects are thought to be related to omega‑3s’ role in regulating inflammatory pathways, prostaglandin production, and uterine contractility. However, results can vary depending on dose, timing, and the mother’s baseline diet.

Maternal Mood and Postpartum Depression

Pregnancy and the postpartum period are times of major hormonal and emotional change. At the same time, the mother’s omega‑3 stores are being used to support the growing baby, which can lower her own levels if intake is not sufficient.

Observational studies have linked lower omega‑3 status with a higher risk of depressive symptoms during and after pregnancy. Some clinical trials suggest that omega‑3 supplementation, particularly EPA‑rich formulas, may help reduce the severity of perinatal and postpartum depression when used alongside standard care.

Proposed mechanisms include:

• Modulation of inflammatory markers that are often elevated in depression

• Effects on neurotransmitters such as serotonin and dopamine

• Support for cell membrane fluidity in brain cells, which can influence receptor function and signaling

• 
  

While omega‑3s are not a replacement for medical treatment, they are increasingly viewed as a supportive strategy for maternal mental health, especially in women with low dietary fish intake.

Safety and Practical Considerations

For pregnant women, both the source and dose of omega‑3s matter.

Food sources:

• Fatty fish such as salmon, sardines, anchovies, and herring provide EPA and DHA.

• It is important to choose low‑mercury options and follow local guidelines on safe fish consumption in pregnancy.

• Plant sources like flaxseeds, chia seeds, and walnuts provide ALA (alpha‑linolenic acid), which the body can convert to EPA and DHA, but the conversion rate is limited.

Supplements:

• Many prenatal supplements now include DHA, and some also provide EPA.

• Typical studied doses in pregnancy range from about 200–600 mg of DHA per day, sometimes combined with EPA.

• Algae‑based DHA supplements are an option for those who do not consume fish.

  
  

Pregnant women should always discuss supplements with their healthcare provider, especially if they have bleeding disorders, are on blood‑thinning medications, or have other medical conditions.

Long‑Term Benefits for Children

Some long‑term follow‑up studies suggest that children whose mothers had higher omega‑3 intake during pregnancy may show:

• Slightly better scores on certain cognitive and attention tests

• Improved visual function

• Potential benefits for behavior and learning in some groups

  
  

However, results are not uniform across all studies, and many factors influence a child’s development, including genetics, environment, and overall nutrition. Omega‑3s appear to be one important piece of a larger puzzle.

Putting It All Together

Current evidence suggests that omega‑3 fatty acids in pregnancy:

• Support healthy brain and eye development in the fetus

• May help reduce the risk of early preterm birth and support healthy birth weight

• Can play a supportive role in maternal mood and may help lower the risk or severity of perinatal depression

• Contribute to long‑term neurodevelopmental outcomes in children, although effects can be modest and vary between individuals

  
  

Omega‑3s are not a stand‑alone solution, but they are a key part of a well‑designed prenatal nutrition plan that also includes balanced macronutrients, adequate vitamins and minerals, regular physical activity as approved by a healthcare provider, and good sleep.

This article is for educational purposes only and is not medical advice.